Changjun Su

Dr. Changjun Su


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2019 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
ZZZhuo Zhang
Zhuo Zhang
JCJinxiang Cheng
Jinxiang Cheng
WYWeiyi Yang
Weiyi Yang
HZHuili Zou
Huili Zou
CSChangjun Su
Changjun Su
JMJianting Miao
Jianting Miao

1 March 2021 in Sleep Medicine
Verified
Journal Article
Closed access
JCJin-Xiang Cheng
Jin-Xiang Cheng
XZXianchao Zhao
Xianchao Zhao
JQJian Qiu
Jian Qiu
YJYingcong Jiang
Yingcong Jiang
JRJiafeng Ren
Jiafeng Ren
CSChangjun Su
Changjun Su

1 January 2004 in World Journal of Gastroenterology
Verified
Journal Article
Open access
LDLi Duan
Li Duan
HYHua Yuan
Hua Yuan
CSChangjun Su
Changjun Su
YLYing-Ying Liu
Ying-Ying Liu
ZRZhi-Ren Rao
Zhi-Ren Rao
Ultrastructure of junction areas between neurons and astrocytes in rat supraoptic nuclei

29 July 2020 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
GCGuo-Yan Chen
Guo-Yan Chen
SZShuai Zhang
Shuai Zhang
CLChong-Hui Li
Chong-Hui Li
CQCong-Cong Qi
Cong-Cong Qi
YWYa-Zhou Wang
Ya-Zhou Wang
CSChangjun Su
Changjun Su
Mammalian Mediator (Med) is a key regulator of gene expression by linking transcription factors to RNA polymerase II (Pol II) transcription machineries. The Mediator subunit 23 (Med23) is a member of the conserved Med protein complex and plays essential roles in diverse biological processes including adipogenesis, carcinogenesis, osteoblast differentiation, and T-cell activation. However, its potential functions in the nervous system remain unknown. We report here that Med23 is required for adult hippocampal neurogenesis in mouse. Deletion of Med23 in adult hippocampal neural stem cells (NSCs) was achieved in Nestin-CreER:Med23flox/flox mice by oral administration of tamoxifen. We found an increased number of proliferating NSCs shown by pulse BrdU-labeling and immunostaining of MCM2 and Ki67, which is possibly due to a reduction in cell cycle length, with unchanged GFAP+/Sox2+ NSCs and Tbr2+ progenitors. On the other hand, neuroblasts and immature neurons indicated by NeuroD and DCX were decreased in number in the dentate gyrus (DG) of Med23-deficient mice. In addition, these mice also displayed defective dendritic morphogenesis, as well as a deficiency in spatial and contextual fear memory. Gene ontology (GO) analysis of hippocampal NSCs revealed an enrichment in genes involved in cell proliferation, Pol II-associated transcription, Notch signaling pathway and apoptosis. These results demonstrate that Med23 plays roles in regulating adult brain neurogenesis and functions.

7 April 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JCJin-Xiang Cheng
Jin-Xiang Cheng
JRJiafeng Ren
Jiafeng Ren
JQJian Qiu
Jian Qiu
YJYingcong Jiang
Yingcong Jiang
XZXianchao Zhao
Xianchao Zhao
CSChangjun Su
Changjun Su
This study aimed to investigate the clinical characteristics and predictors of increased rapid eye movement (REM) sleep or slow wave sleep (SWS) in patients with obstructive sleep apnea (OSA) following positive airway pressure (PAP) therapy. The study retrospectively analyzed data from patients with OSA who underwent both diagnostic polysomnography (PSG) and pressure titration PSG at the Tangdu Hospital Sleep Medicine Center from 2011–2016. Paired diagnostic PSG and pressure titration studies from 501 patients were included. REM rebound was predicted by a higher oxygen desaturation index, lower REM proportion, higher arousal index, lower mean pulse oxygen saturation (SpO2), higher Epworth sleepiness score and younger age (adjusted R2 = 0.482). The SWS rebound was predicted by a longer total duration of apneas and hypopneas, lower N3 duration, lower SpO2 nadir, lower REM proportion in diagnostic PSG and younger age (adjusted R2 = 0.286). Patients without REM rebound or SWS rebound had a high probability of comorbidities with insomnia and mood complaints. Some parameters (subjective and objective insomnia, excessive daytime sleepiness, age and OSA severity) indicate changes in REM sleep and SWS between diagnostic and titration PSG tests. Treatment of insomnia and mood disorders in patients with OSA may helpful to improve the use PAP.

1 December 2007 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
JMJianting Miao
Jianting Miao
HLHongzeng Li
Hongzeng Li
HLHong Lin
Hong Lin
CSChangjun Su
Changjun Su
YLYu Liu
Yu Liu
ZLZhuyi Li
Zhuyi Li